Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women
10 : 193203 Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI
The FDA has approved specific GLP-1 formulations for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Additionally, acute pancreatitis has been reported as a rare adverse effect of GLP-1 therapy
Common symptoms include nausea, vomiting, abdominal pain, diarrhoea, and constipation, which are generally mild to moderate in severity and tend to improve over time
Since starting GLP-1 medication, Ive been tracking my BMR with a RENPHO Smart Scale
US$ 20.90
US$ 29.68
US$ 26.19
US$ 20.49
US$ 22.59
US$ 21.82
US$ 20.02
US$ 25.25
